LOVENOX ANTITRUST SETTLEMENT
Lovenox Settlement – $120,000,000
This settlement alleges that Momenta Pharmaceuticals kept the prices of Lovenox® and generic enoxaparin higher than they otherwise would by manipulating the generic approval process that is required to ensure every batch meets FDA standards. Although Momenta did not develop enoxaparin, it tried to use its patented processes for testing generic enoxaparin to prevent other generic drug manufacturers from producing and selling it. Additionally, this lawsuit also claims that Momenta collaborated with Sandoz and was aware that developing a scheme to monopolize the market would lead to increased profits.
Eligibility Requirements include hospitals, TPP, and patients without insurance who purchased, paid for, and/or reimbursed some or all of the purchase price for generic enoxaparin or Lovenox in class states between September 21, 2011 – September 30, 2015 for the purpose of personal consumption.
The deadline to file for this settlement is September 1, 2020.
For more information regarding other healthcare related settlements that your organization might be eligible for, please see https://classactioncapital.com/cases/healthcare/
Class Action Capital specializes in claim preparation and filing for over 5,000 corporate clients across the country. Our offer is to assist your company in recovering your pro-rata share of the settlement funds by handling all the heavy lifting – including data collection and analysis, claim preparation and filing – on your behalf.
Many companies that we speak with are eligible for these refunds but do not wish to pursue the claims filing internally due to limitations on their time and resources. Additionally, many firms’ data retention policies limit the relevant documentation they can readily gather.
The only thing Class Action Capital needs to get started is for your company to complete our Claim Authorization Form (below). Once completed, we will get to work analyzing your claim to prepare and file for the impending deadline in a timely manner.